The iPLEDGE program is a risk evaluation and mitigation strategy (REMS). The Food and Drug Administration (FDA) may require a REMS to help ensure that a medication’s benefits outweigh its risks. A ...
Please provide your email address to receive an email when new articles are posted on . The AAD and the FDA recommended changes to the iPledge system, but none have yet taken place. The AAD’s iPledge ...
After years of debate and disagreement, could an improved, more user-friendly version of iPLEDGE be on the horizon? iPLEDGE, the US Food and Drug Administration (FDA)-required Risk Evaluation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results